Recursion Provides Business Updates and Reports Fourth

Multiple clinical programs from Recursion’s first generation platform are on track to read out Phase 2 data in H2 2024 and H1 2025 with additional second...

Related Keywords

Toronto ,Ontario ,Canada ,Salt Lake City ,Utah ,United States ,Montreal ,Quebec ,Kristen Rushton ,Chris Gibson ,Twitter ,Recursion Co ,Recursion Pharmaceuticals Inc ,Exchange Commission ,Linkedin ,Youtube ,Development Expenses ,Target Epsilon ,Additional Datasets ,Large Language Model Orchestrated Workflow Engine ,Cavernous Malformation ,Adenomatous Polyposis ,Proficient Ovarian Cancers ,Recursion Co Founder ,Eastern Time ,Business Operations Officer ,Chief Business Operations ,Senior Vice President ,Myriad Genetics ,Shareholder Meeting ,Annual Shareholder Meeting ,Fiscal Year ,Administrative Expenses ,San Francisco Bay ,Balance Sheets ,Securities Litigation Reform Act ,Annual Report ,Fiscal Year Ended December ,Nasdaq Rxrx ,Recursion Pharmaceuticals ,